SCHEMBL13624151

SCHEMBL13624151

O=C(Nc1ccc2nc(-c3cscn3)[nH]c2c1)[C@H]1C[C@@H]1c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 6/20 0.55
LPAR2 Q9HBW0 2/20 0.52
SMN1; SMN2 Q16637 5/20 0.50
NPC1 O15118 4/20 0.50
RAB9A P51151 4/20 0.50
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
MAPT P10636 1/20 0.50
KMT2A Q03164 1/20 0.50
METAP2 P50579 5/20 0.47
TP53 P04637 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CYP2D6 P10635 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
FKBP1A P62942 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4367847 1.00 METAP1 (0.55) METAP1LPAR2SMN1; SMN2NPC1RAB9A
SCHEMBL4377210 1.00 METAP1 (0.55) METAP1LPAR2SMN1; SMN2NPC1RAB9A
SCHEMBL4366029 0.85 METAP1 (0.53) METAP1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL4380056 0.81 LPAR2 (0.57) LPAR2SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL4380066 0.81 LPAR2 (0.57) LPAR2SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL13624132 0.81 METAP1 (0.64) METAP1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL11208586 0.81 METAP1 (0.63) METAP1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL4367952 0.78 EPHX2 (0.52) METAP1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL4366086 0.78 METAP1 (0.51) METAP1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL4367996 0.78 METAP1 (0.60) METAP1SMN1; SMN2NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622592-B2 Carbonylamino-benzimidazole derivatives as androgen receptor modulators MERCK & CO., INC. (US) 2009-11-24 US disclosed